Oncolytics Biotech, Inc. (ONCY)
0.85
+0.01
(+0.82%)
USD |
NASDAQ |
Aug 24, 16:00
0.85
0.00 (0.00%)
After-Hours: 20:00
Oncolytics Biotech Total Liabilities (Quarterly) : 13.84M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 13.84M |
| March 31, 2026 | 13.29M |
| December 31, 2025 | 11.38M |
| September 30, 2025 | 11.49M |
| June 30, 2025 | 10.27M |
| March 31, 2025 | 9.177M |
| December 31, 2024 | 10.12M |
| September 30, 2024 | 11.26M |
| June 30, 2024 | 10.05M |
| March 31, 2024 | 8.706M |
| December 31, 2023 | 8.537M |
| September 30, 2023 | 12.63M |
| June 30, 2023 | 7.351M |
| March 31, 2023 | 7.076M |
| December 31, 2022 | 7.994M |
| September 30, 2022 | 7.687M |
| June 30, 2022 | 7.339M |
| March 31, 2022 | 7.551M |
| December 31, 2021 | 7.744M |
| September 30, 2021 | 7.800M |
| June 30, 2021 | 7.932M |
| March 31, 2021 | 7.567M |
| December 31, 2020 | 7.530M |
| September 30, 2020 | 7.689M |
| June 30, 2020 | 7.794M |
| Date | Value |
|---|---|
| March 31, 2020 | 7.813M |
| December 31, 2019 | 15.24M |
| September 30, 2019 | 9.693M |
| June 30, 2019 | 8.811M |
| March 31, 2019 | 8.055M |
| December 31, 2018 | 6.348M |
| September 30, 2018 | 7.040M |
| June 30, 2018 | 7.394M |
| March 31, 2018 | 7.279M |
| December 31, 2017 | 7.875M |
| September 30, 2017 | 2.224M |
| June 30, 2017 | 2.549M |
| March 31, 2017 | 2.511M |
| December 31, 2016 | 3.034M |
| September 30, 2016 | 2.137M |
| June 30, 2016 | 2.141M |
| March 31, 2016 | 1.975M |
| December 31, 2015 | 1.950M |
| September 30, 2015 | 2.444M |
| June 30, 2015 | 2.450M |
| March 31, 2015 | 3.375M |
| December 31, 2014 | 2.913M |
| September 30, 2014 | 2.952M |
| June 30, 2014 | 3.443M |
| March 31, 2014 | 4.379M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 1.646B |
| Sangamo Therapeutics, Inc. | 78.92M |
| Sarepta Therapeutics, Inc. | 1.661B |
| Anixa Biosciences, Inc. | 1.641M |
| Vicapsys Life Sciences, Inc. | 3.682M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 7.671M |
| Shareholders Equity (Quarterly) | -6.167M |
| Debt to Equity Ratio | -0.0726 |
| Current Ratio | 1.353 |
| Net Debt Paydown Yield | 0.04% |